Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02882841 · ClinicalTrials.gov registry record · NA

MOlecular BIomarkers and Adherent and Invasive Escherichia Coli (AIEC) Detection Study In Crohn's Disease Patients

A NA study, sponsored by Enterome.

Terminated
Registry status
NA
Development phase
143
Enrollment target

NCT02882841: Clinical Trial NA study, sponsored by Enterome.

NCT02882841 is a NA study that was terminated before completion, run by Enterome. The registered enrollment target is 143 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02882841, a NA study, was terminated before completion, sponsored by Enterome.

TERMINATED
Registry status
NA
Development phase
143 participants
Enrollment target

Study Summary

The study is a multicenter, international descriptive study with a bio-collection in 300 evaluable Crohn's disease patients to be processed after usual biological tests via bioinformatics tools. At this time, this study has no impact neither on treatment nor on disease diagnostic, these will be based on usual medical practices and is no investigational product associated with the conduct of this study.

Interventions

  • OTHER Biopsies, stool and blood collection

Trial Details

FieldValue
Enrollment Target 143 participants
Start Date 2016-09
Est. Completion 2017-12
Phase NA
Enterome

6 total trials

Why NCT02882841 stopped before completion

NCT02882841 is an interventional study that assigns participants to a tested intervention. The registered 143 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).

The record links to 0 conditions, and to 1 intervention - of which Biopsies, stool and blood collection is the first listed.

NCT02882841 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02882841 about?

NCT02882841 is a clinical study titled "MOlecular BIomarkers and Adherent and Invasive Escherichia Coli (AIEC) Detection Study In Crohn's Disease Patients". The study is a multicenter, international descriptive study with a bio-collection in 300 evaluable Crohn's disease patients to be processed after usual biological tests via bioinformatics tools. At this time, this study has no impact neither on treatment nor on disease diagnostic, these will be bas...

What is the current status of trial NCT02882841?

This trial is currently terminated. It is a NA study. The enrollment target is 143 participants. The study started on 2016-09. Estimated completion is 2017-12.

What interventions are being tested in trial NCT02882841?

The interventions under investigation include: Biopsies, stool and blood collection (OTHER).

Who is sponsoring clinical trial NCT02882841?

This trial is sponsored by Enterome, which has 6 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02882841's enrollment target sits among peer trials

143 711th of 2000 higher than 1,290 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01861106 · 144 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations

  • NCT03482245 · 144 participants · NA

    The Role of Circadian Clock Proteins in Innate and Adaptive Immunity

  • NCT03504683 · 144 participants · NA

    MEAL TIMING Study: Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults With Prediabetes

  • NCT03905603 · 144 participants · Early Phase 1

    Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02882841, the US trial registry maintained by the National Library of Medicine. NCT02882841 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.